The cash flow of S&P Global Inc. over the past 10 years
Chart S&P Global Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, S&P Global Inc.'s operating cash flow was $5.65B and its capital expenditures $195M, leaving free cash flow of $5.46B. Free cash flow was above zero in all 10 years shown. It ranged from $1.45B in fiscal 2016 to $5.57B in fiscal 2024. Capital expenditures were highest in fiscal 2025, at $195M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $5.65B | $195M | $5.46B |
| 2024ended Dec 31, 2024 | $5.69B | $124M | $5.57B |
| 2023ended Dec 31, 2023 | $3.71B | $143M | $3.57B |
| 2022ended Dec 31, 2022 | $2.6B | $89M | $2.51B |
| 2021ended Dec 31, 2021 | $3.6B | $35M | $3.56B |
| 2020ended Dec 31, 2020 | $3.57B | $76M | $3.49B |
| 2019ended Dec 31, 2019 | $2.78B | $115M | $2.66B |
| 2018ended Dec 31, 2018 | $2.06B | $113M | $1.95B |
| 2017ended Dec 31, 2017 | $2.02B | $123M | $1.89B |
| 2016ended Dec 31, 2016 | $1.56B | $115M | $1.45B |
Fiscal years as S&P Global Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on S&P Global Inc.
- The revenue of S&P Global Inc.
- The profitability of S&P Global Inc.
- The debt of S&P Global Inc.
- The dividends of S&P Global Inc.
- All of S&P Global Inc.'s financials, charted
Companies of a similar size
- UBERUber Technologies, Inc
- VRTXVERTEX PHARMACEUTICALS INC / MA
- LMTLOCKHEED MARTIN CORPORATION
- PGRPROGRESSIVE CORP/OH/
- CBChubb Limited
Not investment advice. This page shows what S&P Global Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.